The Community Guide

- gsearch

Search Results

Narrow Results:

2021 2

Journal Article 2

1 - 2 of 2 Results

Refine Results

Refine Results:

Expected implications of globally-coordinated cessation of serotype 3 oral poliovirus vaccine (OPV) before serotype 1 OPV

CITE Title : Expected implications of globally-coordinated cessation of serotype 3 oral poliovirus vaccine (OPV) before serotype 1 OPV Personal Author(s) : Kalkowska, Dominika A.;Thompson, Kimberly M.; Published Date : 2 2021;2-2021; Source : Risk Anal. 41(2):312-319 URL : https://stacks.cdc.gov/view/cdc/153687 Kalkowska, Dominika A. and Thompson, Kimberly M. (2021). Expected implications of globally-coordinated cessation of serotype 3 oral poliovirus vaccine (OPV) before serotype 1 OPV. 41(2). Kalkowska, Dominika A. and Thompson, Kimberly M. "Expected implications of globally-coordinated cessation of serotype 3 oral poliovirus vaccine (OPV) before serotype 1 OPV" 41, no. 2 (2021) Kalkowska, Dominika A. and Thompson, Kimberly M. "Expected implications of globally-coordinated cessation of serotype 3 oral poliovirus vaccine (OPV) before serotype 1 OPV" vol. 41, no. 2, 2021 Export RIS Citation Information.

:

Kalkowska, Dominika A. ;

Thompson, Kimberly M.

2 2021 | Risk Anal. 41(2):312-319

:

Globally coordinated cessation of all three serotypes of oral poliovirus vaccine (OPV) represents a critical part of a successful polio endgame, which...
Updated characterization of post-OPV cessation risks: Lessons from 2019 serotype 2 outbreaks and implications for the probability of OPV restart

CITE Title : Updated characterization of post-OPV cessation risks: Lessons from 2019 serotype 2 outbreaks and implications for the probability of OPV restart Personal Author(s) : Kalkowska, Dominika A.;Pallansch, Mark A.;Cochi, Stephen L.;Kovacs, Stephanie D.;Wassilak, Steven G. F.;Thompson, Kimberly M.; Published Date : 2 2021;2-2021; Source : Risk Anal. 41(2):320-328 URL : https://stacks.cdc.gov/view/cdc/100696 Kalkowska, Dominika A. et al. (2021). Updated characterization of post-OPV cessation risks: Lessons from 2019 serotype 2 outbreaks and implications for the probability of OPV restart. 41(2). Kalkowska, Dominika A. et al. "Updated characterization of post-OPV cessation risks: Lessons from 2019 serotype 2 outbreaks and implications for the probability of OPV restart" 41, no. 2 (2021) Kalkowska, Dominika A. et al. "Updated characterization of post-OPV cessation risks: Lessons from 2019 serotype 2 outbreaks and implications for the probability of OPV restart" vol. 41, no. 2, 2021 Export RIS Citation Information.

:

Kalkowska, Dominika A. ;

Pallansch, Mark A.

2 2021 | Risk Anal. 41(2):320-328

:

After the globally coordinated cessation of any serotype of oral poliovirus vaccine (OPV), some risks remain from undetected, existing homotypic OPV-r...